David Martin on health care stocks
Some years ago brokers would be inclined not to invest on health care stocks.
Due to scenario changes and a lot of investment opportunities showing potential for substantial returns.
David Martin, Managing Director and Head of Equity Research at Bloom Burton comments on how he identifies the best health care stocks.
Specialty pharmaceuticals and the biotech market shows growing investments and penetration in Canada’s market.
Companies with better drug design and development methodologies and processes. Combined to a broader and more detailed information on the genetics of the diseases are creating more good biotech if compared to the last five to ten years.
David states that the pharmaceutical market is most noteworthy focusing on immuno-oncology and orphan diseases. Medications that brings significant value per patient to the table.